EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”

Molecular Oncology · 2026-08 · 20 (8) · 2129-2130

DOI: 10.1002/1878-0261.70297 ↗

Kurz gefasst

Korrektur in der Zeitschrift Molecular Oncology, online erschienen am 12.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”. Molecular Oncology, 20(8), 2129-2130. https://doi.org/10.1002/1878-0261.70297

Vancouver

Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”. Molecular Oncology. 2026;20(8):2129-2130. doi:10.1002/1878-0261.70297

BibTeX
@article{euvimed2026,
  title = {Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”},
  journal = {Molecular Oncology},
  year = {2026},
  volume = {20},
  number = {8},
  pages = {2129--2130},
  doi = {10.1002/1878-0261.70297}
}
Kostenlos starten →